Aging and obesity are synergistic sarcopenia risk factors (RF). Their association in
sarcopenic obesity (SO) enhances morbidity and mortality, but consensus on SO diagnostic …

Background Although the prevalence of sarcopenic obesity is increasing, nowadays a
universally accepted definition still does not exist. Because, this clinical entity is defined as …

Introduction: Loss of skeletal muscle mass and function (sarcopenia) is common in
individuals with obesity due to metabolic changes associated with a sedentary lifestyle …

The concept of sarcopenic obesity (SO) has gained a considerable attention in scientific
area and a plenty of reports have been published in recent years. Besides the mixed results …

Background & aims Sarcopenic obesity (SO) is defined by a relatively low muscle mass in
combination with obesity. Sarcopenic obesity was first noted as a health risk in geriatric …

Objective The recent consensus statement of ESPEN and EASO recommends reviewing
existing datasets to assess the prevalence of sarcopenic obesity based on the new definition …

Background The aim of this study is to identify the prevalence, assess the metabolic profile,
and key differences (versus healthy) in a cohort of subjects with sarcopenia (S) and in …

Background & aims The potential for older adults with obesity to also have sarcopenia, and
the health consequences of 'sarcopenic obesity', may be underappreciated by health …

Background The combined effect of sarcopenia and obesity, ie, sarcopenic obesity, has
been associated with disability and worse outcomes in older adults, but results are …

Objectives Following the concept of a metabolic load-capacity model, we propose the use of
appendicular skeletal muscle mass (ASM) to total body fat (TBF) ratio in predicting 4-year …